BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22296381)

  • 1. No association between the CYP1B1 C4326G polymorphism and endometrial cancer risk: a meta-analysis.
    Wang XW; Chen YL; Luo YL; Liu QY
    Asian Pac J Cancer Prev; 2011; 12(9):2343-8. PubMed ID: 22296381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.
    Wang F; Zou YF; Sun GP; Su H; Huang F
    Eur J Cancer Prev; 2011 Mar; 20(2):112-20. PubMed ID: 21191305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
    Teng Y; He C; Zuo X; Li X
    Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women.
    Li Y; Tan SQ; Ma QH; Li L; Huang ZY; Wang Y; Li SW
    Tumour Biol; 2013 Dec; 34(6):3561-7. PubMed ID: 23794133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis: a meta-analysis.
    Wang X; Xiao H; Lan H; Mao C; Chen Q
    Respirology; 2011 Jul; 16(5):790-5. PubMed ID: 21470339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
    McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
    Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.
    Qin TT; Chen T; Zhang Q; Du HN; Shu YQ; Luo K; Zhu LJ
    Biomed Pharmacother; 2014 Sep; 68(7):905-10. PubMed ID: 25194442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CYP1B1 gene polymorphisms and the positive expression of estrogen alpha and estrogen beta with endometrial cancer risk.
    Zhu ZY; Mu YQ; Fu XM; Li SM; Zhao FX
    Eur J Gynaecol Oncol; 2011; 32(2):188-91. PubMed ID: 21614911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.
    Xie Y; Liu GQ; Miao XY; Liu Y; Zhou W; Zhong DW
    Tumour Biol; 2012 Jun; 33(3):809-16. PubMed ID: 22190224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.
    Liu Y; Lin CS; Zhang AM; Song H; Fan CC
    Tumour Biol; 2014 May; 35(5):4719-25. PubMed ID: 24453031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.
    Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1515-20. PubMed ID: 15342454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the ERalpha and CYP1B1 genes in endometrial cancer in a Polish subpopulation.
    Sliwinski T; Sitarek P; Stetkiewicz T; Sobczuk A; Blasiak J
    J Obstet Gynaecol Res; 2010 Apr; 36(2):311-7. PubMed ID: 20492382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer].
    Zimarina TC; Kristensen VN; Imianitov EN; Bershteĭn LM
    Mol Biol (Mosk); 2004; 38(3):386-93. PubMed ID: 15285606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk.
    Shen M; Hu YY; Hu YK; Xie LC; Xu XM; Wu MY; Niu YM
    Tumour Biol; 2014 Apr; 35(4):3891-7. PubMed ID: 24343338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
    Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
    Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis.
    Mandal RK; Yadav SS; Panda AK
    Tumour Biol; 2014 Sep; 35(9):8607-13. PubMed ID: 24863946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.
    Mei Q; Zhou D; Han J; Lu H; Tang B
    Metabolism; 2012 Sep; 61(9):1321-9. PubMed ID: 22459615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions.
    Sasaki M; Tanaka Y; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jul; 63(14):3913-8. PubMed ID: 12873984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible association between the presence of an MPO -463 G > A (rs2333227) polymorphism and cervical cancer risk.
    Shi X; Li B; Yuan Y; Chen L; Zhang Y; Yang M; Wang J; Qin D
    Pathol Res Pract; 2018 Aug; 214(8):1142-1148. PubMed ID: 29937309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
    Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
    Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.